Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
GS Stock Summary
Top 10 Correlated ETFs
GS
In the News

U.S. Money Supply Is Shrinking the Most Since the Great Depression. Does It Spell Doom for the Stock Market in 2024?
U.S. money supply is declining rapidly. Previous significant money supply contractions have been followed by major economic downturns.

BT boosts ‘confidence' in Openreach fibre build: Goldman
Goldman Sachs (NYSE:GS) analysts have reiterated the bank's ‘buy' rating for BT Group PLC (LSE:BT.A), following the company's Openreach analyst day. Openreach is BT's fixed broadband digital infrastructure wholesale business, representing almost half of the group's underlying earnings (EBITDA).

Key Takeaways From Executive Conference About Capital Markets
Global financial firms - JPMorgan (JPM), Goldman (GS), Citigroup (C) and Bank of America (BAC) - are expecting the operating backdrop to turn favorable for capital markets businesses.

Big bank CEOs testify before Congress: Top takeaways
The CEOs of America's largest banks, including Bank of America (BAC) Chairman and CEO Brian Moynihan, JPMorgan Chase (JPM) Chairman and CEO Jamie Dimon, Citigroup (C) CEO Jane Fraser, and more, testified before the Senate's banking committee as part of Congress's annual oversight of the financial sector. The controversial capital requirements proposed by the Federal Reserve came up repeatedly throughout the hearing, with many CEOs opposed to the provisions or in favor of amendments before the requirements go into effect.

Wall Street CEOs say proposed banking rules will hurt small businesses, low-income Americans
The heads of America's largest banks, including JPMorgan Chase, Bank of America and Goldman Sachs are seeking to dull the impact of the new rules.

Bankers Push Back Against Basel III Endgame Rules
The heads of Wall Street's biggest banks took their most direct swing yet at Washington's plans to force them to set aside more cash as a buffer against losses. Here are some highlights from their testimony before the Senate Banking Committee.

Bank CEOs criticize newly proposed capital rules in Senate hearing
CNBC's Leslie Picker reports on the latest news from the big bank CEOs' testimony on Capitol Hill.

Goldman CEO Warns New Bank Rules ‘Punitive' to Economic Growth
Goldman Sachs Group Inc. Chief Executive Officer David Solomon explains the depth of existing stress banking tests and says the proposed rules are “a wholesale change that leads to problems.” Solomon testifies about the US government's proposed bank regulatory plans Wednesday before the Senate Banking Committee.

Big bank CEOs testify in Senate hearing
The CEOs of Wall Street's biggest banks testify in front of the Senate Banking Committee.

Mortgages and small loans will be more expensive under proposed regulations, bank chiefs say
The chief executives of big U.S. banks are arguing that banking regulations aimed at strengthening the country's financial system will instead hurt the economy.
GS Financial details
GS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 86.7 | 89.6 | 113.41 | 171.2 | 136.66 | |
Net income per share | 27.14 | 22.78 | 26.54 | 62.42 | 32.49 | |
Operating cash flow per share | 52.99 | 64.23 | -38.52 | 2.66 | 25.12 | |
Free cash flow per share | 32.28 | 41.51 | -56.22 | -10.81 | 14.31 | |
Cash per share | 337.31 | 357.91 | 439.19 | 753.1 | 1.72K | |
Book value per share | 233.52 | 242.2 | 269.36 | 317.37 | 337.56 | |
Tangible book value per share | 222.93 | 229.18 | 255.44 | 303.8 | 313.38 | |
Share holders equity per share | 233.52 | 242.2 | 269.36 | 317.37 | 337.56 | |
Interest debt per share | 728.88 | 732.98 | 771.43 | 884.74 | 950.22 | |
Market cap | 64.38B | 85.44B | 93.99B | 132.59B | 119.02B | |
Enterprise value | 199.38B | 207.44B | 203.99B | 172.59B | -39.93B | |
P/E ratio | 6.16 | 10.09 | 9.94 | 6.13 | 10.57 | |
Price to sales ratio | 1.93 | 2.57 | 2.33 | 2.23 | 2.51 | |
POCF ratio | 3.15 | 3.58 | -6.85 | 143.97 | 13.67 | |
PFCF ratio | 5.18 | 5.54 | -4.69 | -35.4 | 24 | |
P/B Ratio | 0.72 | 0.95 | 0.98 | 1.21 | 1.02 | |
PTB ratio | 0.72 | 0.95 | 0.98 | 1.21 | 1.02 | |
EV to sales | 5.97 | 6.23 | 5.05 | 2.91 | -0.84 | |
Enterprise value over EBITDA | 6.71 | 16.88 | 14.18 | 5.94 | -1.07 | |
EV to operating cash flow | 9.76 | 8.69 | -14.86 | 187.4 | -4.59 | |
EV to free cash flow | 16.03 | 13.45 | -10.18 | -46.07 | -8.05 | |
Earnings yield | 0.16 | 0.1 | 0.1 | 0.16 | 0.09 | |
Free cash flow yield | 0.19 | 0.18 | -0.21 | -0.03 | 0.04 | |
Debt to equity | 2.94 | 2.83 | 2.77 | 2.74 | 2.63 | |
Debt to assets | 0.28 | 0.26 | 0.23 | 0.21 | 0.21 | |
Net debt to EBITDA | 4.54 | 9.93 | 7.65 | 1.38 | -4.26 | |
Current ratio | 2.83 | 0.93 | 1.14 | 1.41 | 1.22 | |
Interest coverage | 1.78 | 0.61 | 1.4 | 4.79 | 1.63 | |
Income quality | 1.95 | 2.82 | -1.45 | 0.04 | 0.77 | |
Dividend Yield | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | |
Payout ratio | 0.17 | 0.25 | 0.25 | 0.13 | 0.33 | |
Sales general and administrative to revenue | 0.37 | 0.37 | 0.33 | 0.3 | 0.32 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0.01 | |
Capex to operating cash flow | -0.39 | -0.35 | 0.46 | -5.07 | -0.43 | |
Capex to revenue | -0.24 | -0.25 | -0.16 | -0.08 | -0.08 | |
Capex to depreciation | -6.01 | -4.95 | -3.32 | -2.32 | -1.53 | |
Stock based compensation to revenue | 0.05 | 0.06 | 0.05 | 0.04 | 0.09 | |
Graham number | 377.61 | 352.35 | 401.06 | 667.63 | 496.76 | |
ROIC | 0.07 | 0.02 | 0.03 | 0.05 | 0.07 | |
Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham Net | -884.8 | -1.92K | -2.3K | -2.8K | -1.81K | |
Working capital | 405B | -15B | 33.53B | 123.03B | 72.19B | |
Tangible asset value | 85.92B | 85.16B | 91.04B | 105.3B | 108.62B | |
Net current asset value | -217B | -695B | -789.47B | -930.98B | -922.97B | |
Invested capital | 2.94 | 2.83 | 2.77 | 2.74 | 2.63 | |
Average receivables | 295B | 285.5B | 98B | 141B | 148.22B | |
Average payables | 179B | 177.5B | 183B | 221.5B | 257B | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 5.42K | 822.22 | 1.09K | 990.33 | 1.04K | |
Days payables outstanding | 5K | 4.77K | 4.89K | 4.92K | 5.91K | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.07 | 0.44 | 0.33 | 0.37 | 0.35 | |
Payables turnover | 0.07 | 0.08 | 0.07 | 0.07 | 0.06 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.12 | 0.09 | 0.1 | 0.2 | 0.1 | |
Capex per share | -20.71 | -22.72 | -17.7 | -13.47 | -10.81 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 33.94 | 30.31 | 35.27 | 31.83 | 34.89 | |
Net income per share | 8.7 | 3.79 | 9.33 | 3.55 | 6.08 | |
Operating cash flow per share | 23.19 | -42.91 | 27.13 | 93.2 | -75.39 | |
Free cash flow per share | 20.39 | -45.07 | 25.41 | 91.25 | -76.89 | |
Cash per share | 1.68K | 1.71K | 1.86K | 879.6 | 827.93 | |
Book value per share | 337.3 | 334.76 | 337.56 | 338.88 | 345.44 | |
Tangible book value per share | 313.91 | 310.78 | 313.32 | 315.91 | 324.02 | |
Share holders equity per share | 337.3 | 334.76 | 337.56 | 338.88 | 345.44 | |
Interest debt per share | 846.11 | 910.84 | 920.82 | 923.61 | 917.36 | |
Market cap | 103.39B | 120.01B | 113.38B | 110.41B | 109.59B | |
Enterprise value | -71.36B | -38.93B | 190.38B | 140.41B | 163.59B | |
P/E ratio | 8.42 | 22.63 | 8.76 | 22.7 | 13.31 | |
Price to sales ratio | 8.63 | 11.33 | 9.27 | 10.13 | 9.27 | |
POCF ratio | 12.63 | -8 | 12.06 | 3.46 | -4.29 | |
PFCF ratio | 14.37 | -7.62 | 12.87 | 3.53 | -4.21 | |
P/B Ratio | 0.87 | 1.03 | 0.97 | 0.95 | 0.94 | |
PTB ratio | 0.87 | 1.03 | 0.97 | 0.95 | 0.94 | |
EV to sales | -5.96 | -3.68 | 15.57 | 12.89 | 13.84 | |
Enterprise value over EBITDA | -6.97 | -3.09 | 10.72 | 59.98 | 48.06 | |
EV to operating cash flow | -8.72 | 2.6 | 20.24 | 4.4 | -6.41 | |
EV to free cash flow | -9.92 | 2.47 | 21.62 | 4.5 | -6.28 | |
Earnings yield | 0.03 | 0.01 | 0.03 | 0.01 | 0.02 | |
Free cash flow yield | 0.07 | -0.13 | 0.08 | 0.28 | -0.24 | |
Debt to equity | 2.45 | 2.63 | 2.62 | 2.59 | 2.51 | |
Debt to assets | 0.19 | 0.21 | 0.2 | 0.19 | 0.19 | |
Net debt to EBITDA | -17.06 | -12.62 | 4.33 | 12.82 | 15.86 | |
Current ratio | 1.39 | 1.22 | 1.13 | 1.3 | 1.18 | |
Interest coverage | 1.47 | 1.15 | 1.3 | 0.11 | 0.16 | |
Income quality | 2.67 | -11.31 | 2.91 | 26.23 | -12.41 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.32 | 0.76 | 0.31 | 0.83 | 0.53 | |
Sales general and administrative to revenue | 0.3 | 0.36 | 0.33 | 0.33 | 0.35 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Capex to operating cash flow | -0.12 | 0.05 | -0.06 | -0.02 | 0.02 | |
Capex to revenue | -0.08 | -0.07 | -0.05 | -0.06 | -0.04 | |
Capex to depreciation | -1.49 | -1.04 | -0.62 | -0.42 | -0.34 | |
Stock based compensation to revenue | 0.03 | 0.03 | 0.13 | 0.02 | 0.02 | |
Graham number | 256.94 | 169.05 | 266.21 | 164.58 | 217.32 | |
ROIC | 0.02 | 0.02 | 0.03 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | -2.04K | -1.79K | -1.93K | -3.03K | -3.17K | |
Working capital | 131.42B | 72.19B | 43B | 100B | 58B | |
Tangible asset value | 110.75B | 108.62B | 108.6B | 108.14B | 109.75B | |
Net current asset value | -968.35B | -922.97B | 1047B | 1027B | 1079B | |
Invested capital | 2.45 | 2.63 | 2.62 | 2.59 | 2.51 | |
Average receivables | 164.34B | 150.43B | 140.22B | 151B | 149B | |
Average payables | 279.5B | 270.5B | 264B | 262B | 255.5B | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 1.24K | 1.15K | 1.07K | 1.3K | 1.07K | |
Days payables outstanding | 6.5K | 1.46K | 5.5K | 6K | 5.11K | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.07 | 0.08 | 0.08 | 0.07 | 0.08 | |
Payables turnover | 0.01 | 0.06 | 0.02 | 0.02 | 0.02 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.03 | 0.01 | 0.03 | 0.01 | 0.02 | |
Capex per share | -2.81 | -2.16 | -1.72 | -1.95 | -1.5 |
GS Frequently Asked Questions
What is The Goldman Sachs Group, Inc. stock symbol ?
The Goldman Sachs Group, Inc. is a US stock , located in New york of Ny and trading under the symbol GS
Is The Goldman Sachs Group, Inc. buy or a sell ?
34 stock analysts have 34 predictions with a medium analyst target price of $418.84. The lowest prediction is $290 and the highest is $546
What is GS stock prediction ?
With a median analyst target price of $396.67, 3 stock analysts have made 3 forecasts in last 90 days. $329 is the lowest and $440 is the greatest projection.
What is The Goldman Sachs Group, Inc. stock quote today ?
The Goldman Sachs Group, Inc. stock price is $351.44 today.
Is The Goldman Sachs Group, Inc. stock public?
Yes, The Goldman Sachs Group, Inc. is a publicly traded company.